A peptide related to thymosin beta-4, studied in research on actin regulation, cellular migration, and tissue repair signaling pathways. It is widely used in laboratory investigations examining cytoskeletal dynamics, angiogenesis, and inflammatory response modulation.
TB-500 is a peptide studied in relation to thymosin beta-4 biology and the broader signaling systems involved in cellular structure, migration, and vascular response. In research settings, it is commonly used to examine how actin-associated pathways and peptide-mediated signaling influence structural and cellular coordination.
TB-500 is studied for its relationship to thymosin beta-4-associated pathway activity, particularly in connection with G-actin binding and actin-regulated cellular dynamics. In laboratory research, this makes it useful for examining cell migration, cytoskeletal organization, angiogenic signaling, and broader structural pathway coordination. It is commonly used in studies involving connective tissue biology, vascular signaling, actin-regulated cellular behavior, and peptide-mediated structural response models.
Research on TB-500 developed from broader interest in thymosin beta-4 and its role in actin-binding biology. Over time, TB-500 became a commonly used name in peptide research markets for compounds studied in structural and vascular pathway models.
For research use only. Not for human or veterinary use. Detailed storage guidelines →